Insmed | INSM

Aktienkurs
112.58
Täglich Wechseln
0.99 0.89%
Monatlich
3.67%
Jährlich
-40.62%
Q4 Prognose
91.41

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-29 FY2026Q3 AM -0.46 -0.61 -1.75
2026-08-06 FY2026Q2 AM -0.06 -0.75 -1.70
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 58.51 1.02 1.77% 9.22% 2026-10-30
Cytokinetics 62.99 -0.32 -0.51% -0.94% 2026-10-30
DBV Technologies 9.49 -0.80 -7.77% -35.18% 2026-10-30
Gilead Sciences 170.68 5.07 3.06% 42.48% 2026-10-30
Heron Therapeutics 0.28 -0.02 -5.44% -76.03% 2026-10-30
Insmed 112.58 0.99 0.89% -40.62% 2026-10-30
Novartis 160.79 -0.26 -0.16% 29.75% 2026-10-30
Ultragenyx Pharmaceutical 16.10 -0.68 -4.05% -53.47% 2026-10-30
Regeneron Pharmaceuticals 927.89 109.12 13.33% 42.36% 2026-10-30
Sarepta Therapeutics 18.62 -0.61 -3.17% -22.45% 2026-10-30

Preis Tag Jahr Datum
USND 25437 -747.73 -2.86% 7.22% 2026-10-30
US Index 2000 2812 -47.45 -1.66% 13.41% 2026-10-30